{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:44:02Z","timestamp":1793738642947,"version":"4.6.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"DMU Locomotion","award":["Interessement rescherche 2021"],"award-info":[{"award-number":["Interessement rescherche 2021"]}]},{"name":"ArtViggo"},{"name":"Prevention et Traitement des D\u00e9calcifications"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1136\/ard-2023-225305","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T18:20:16Z","timestamp":1708366816000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker"],"prefix":"10.1016","volume":"83","author":[{"given":"Hang-Korng","family":"Ea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Kischkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twinu Wilson","family":"Chirayath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Kl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang-Uyen","family":"Loeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Manivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myl\u00e8ne","family":"Zarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Liot\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Latourte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Gauffenic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Octavia","family":"Crisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-225305_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13937","article-title":"Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019","volume":"53","author":"Jeong","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"10.1136\/ard-2023-225305_bib2","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"The Lancet"},{"key":"10.1136\/ard-2023-225305_bib3","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"The Lancet"},{"key":"10.1136\/ard-2023-225305_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.2022.11390","article-title":"Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout","volume":"328","author":"Cipolletta","year":"2022","journal-title":"JAMA"},{"key":"10.1136\/ard-2023-225305_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/acr2.11540","article-title":"Risk of Major Adverse Cardiovascular Event Following Incident Hospitalization for Acute Gout: A Western Australian Population-Level Linked Data Study","volume":"5","author":"Lopez","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1136\/ard-2023-225305_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2021-000081","article-title":"Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand","volume":"1","author":"Cai","year":"2022","journal-title":"BMJ Med"},{"key":"10.1136\/ard-2023-225305_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","article-title":"Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options","volume":"15","author":"Bardin","year":"2017","journal-title":"BMC Med"},{"key":"10.1136\/ard-2023-225305_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.24185","article-title":"Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout","volume":"60","author":"Martin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225305_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02248","article-title":"Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-\u03baB Activation and MAPK Pathways","volume":"9","author":"Campillo-Gimenez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-225305_bib10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/annrheumdis-2020-217342","article-title":"Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1\u03b2 activation on macrophages","volume":"79","author":"Renaudin","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225305_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1136\/ard-2023-225305_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110489","article-title":"Monosodium urate crystals regulate a unique JNK-dependent macrophage metabolic and inflammatory response","volume":"38","author":"Cobo","year":"2022","journal-title":"Cell Rep"},{"key":"10.1136\/ard-2023-225305_bib13","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225305_bib14","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225305_bib15","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.41699","article-title":"A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares","volume":"73","author":"Saag","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225305_bib16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/key402","article-title":"Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial","volume":"58","author":"Janssen","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225305_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80455-0","article-title":"LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator","volume":"8","author":"Mauri","year":"1998","journal-title":"Immunity"},{"key":"10.1136\/ard-2023-225305_bib18","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220236","article-title":"Realigning the LIGHT signaling network to control dysregulated inflammation","volume":"219","author":"Ware","year":"2022","journal-title":"J Exp Med"},{"key":"10.1136\/ard-2023-225305_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/biomedicines10020264","article-title":"Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries","volume":"10","author":"Qu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1136\/ard-2023-225305_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"10.1136\/ard-2023-225305_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1182\/blood-2005-09-010629","article-title":"Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes","volume":"108","author":"Otterdal","year":"2006","journal-title":"Blood"},{"key":"10.1136\/ard-2023-225305_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejheart.2008.02.010","article-title":"Increased expression of LIGHT\/TNFSF14 and its receptors in experimental and clinical heart failure","volume":"10","author":"Dahl","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1136\/ard-2023-225305_bib23","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1136\/ard-2023-225305_bib24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41374-022-00798-4","article-title":"Distinct macrophage polarization in acute and chronic gout","volume":"102","author":"Zhao","year":"2022","journal-title":"Lab Invest"},{"key":"10.1136\/ard-2023-225305_bib25","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jid.2021.10.028","article-title":"The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts","volume":"142","author":"Ikawa","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard-2023-225305_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114791","article-title":"Lymphotoxin \u03b2 receptor signaling induces IL-8 production in human bronchial epithelial cells","volume":"9","author":"Mikami","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1136\/ard-2023-225305_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcb.22109","article-title":"Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation","volume":"107","author":"Heo","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1136\/ard-2023-225305_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K","article-title":"The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis","volume":"41","author":"Terkeltaub","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225305_bib29","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","article-title":"Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8), Myeloid-Related Protein 8\/Myeloid-Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease","volume":"67","author":"Kienhorst","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225305_bib30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/rheumatology\/kem063","article-title":"The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis","volume":"46","author":"Pierer","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225305_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133435","article-title":"Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets","volume":"14","author":"Barbarroja","year":"2023","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-225305_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11373-005-1360-5","article-title":"Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells","volume":"12","author":"Chang","year":"2005","journal-title":"J Biomed Sci"},{"key":"10.1136\/ard-2023-225305_bib33","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.celrep.2015.12.004","article-title":"Intratumoral LIGHT Restores Pericyte Contractile Properties and Vessel Integrity","volume":"13","author":"Johansson-Percival","year":"2015","journal-title":"Cell Rep"},{"key":"10.1136\/ard-2023-225305_bib34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1524-475X.2008.00411.x","article-title":"Vascular endothelial growth factor promotes macrophage apoptosis through stimulation of tumor necrosis factor superfamily member 14 (TNFSF14\/LIGHT)","volume":"16","author":"Petreaca","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1136\/ard-2023-225305_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153173","article-title":"Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome","volume":"132","author":"Perlin","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1136\/ard-2023-225305_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"K\u00f6ttgen","year":"2013","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2023-225305_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor A","volume":"24","author":"P\u00e9rez-Guti\u00e9rrez","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl 3","key":"10.1136\/ard-2023-225305_bib38","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1186\/ar562","article-title":"Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response","volume":"4","author":"Haskard","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1136\/ard-2023-225305_bib39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.1780400525","article-title":"Endothelial activation in Monosodium Urate Monohydrate crystal-induced inflammation. In: In vitro and in vivo studies on the roles of tumor necrosis factor \u03b1 and interleukin-1","volume":"40","author":"Chapman","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225305_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110309","article-title":"Macrophage IL-1\u03b2 promotes arteriogenesis by autocrine STAT3- and NF-\u03baB-mediated transcription of pro-angiogenic VEGF-A","volume":"38","author":"Mantsounga","year":"2022","journal-title":"Cell Rep"},{"key":"10.1136\/ard-2023-225305_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1535370219830665","article-title":"Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation","volume":"244","author":"Zamudio-Cuevas","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1136\/ard-2023-225305_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050924","article-title":"Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway","volume":"7","author":"Lin","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1136\/ard-2023-225305_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/annrheumdis-2011-200711","article-title":"Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor \u03b21 in the resolution phase","volume":"71","author":"Scanu","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225305_bib44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/15353702221087966","article-title":"Identification in synovial fluid of a new potential pathogenic player in arthropathies","volume":"247","author":"Scanu","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1136\/ard-2023-225305_bib45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat Med"},{"key":"10.1136\/ard-2023-225305_bib46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","article-title":"Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra","volume":"75","author":"Crisan","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225305_bib47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard-2023-225305_bib48","doi-asserted-by":"crossref","first-page":"L1040","DOI":"10.1152\/ajplung.00333.2004","article-title":"Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta","volume":"288","author":"Faffe","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1136\/ard-2023-225305_bib49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/glia.10182","article-title":"Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide","volume":"42","author":"Repovic","year":"2003","journal-title":"Glia"},{"key":"10.1136\/ard-2023-225305_bib50","doi-asserted-by":"crossref","first-page":"29681","DOI":"10.1074\/jbc.M802076200","article-title":"Identification of proteins binding to E-Box\/Ku86 sites and function of the tumor suppressor SAFB1 in transcriptional regulation of the human xanthine oxidoreductase gene","volume":"283","author":"Lin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1136\/ard-2023-225305_bib51","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08820139.2016.1153651","article-title":"Cytokine Profile in Gout: Inflammation Driven by IL-6 and IL-18?","volume":"45","author":"Cavalcanti","year":"2016","journal-title":"Immunological Investigations"},{"key":"10.1136\/ard-2023-225305_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.06.972","article-title":"Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials","volume":"379","author":"Li","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1136\/ard-2023-225305_bib53","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2023-225305_bib54","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2023-225305_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCRESAHA.108.188078","article-title":"Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis","volume":"104","author":"Sandberg","year":"2009","journal-title":"Circ Res"},{"key":"10.1136\/ard-2023-225305_bib56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2015.07.023","article-title":"Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis","volume":"242","author":"Lind","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1136\/ard-2023-225305_bib57","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s00125-016-4036-y","article-title":"LIGHT\/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro","volume":"59","author":"Halvorsen","year":"2016","journal-title":"Diabetologia"},{"key":"10.1136\/ard-2023-225305_bib58","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-225305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:02:05Z","timestamp":1736056925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0003496724000748"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-225305","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc. on behalf of EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}